Veraxa Biotech AG VRXA

Full chart Compare
Set alert

Price alert · VRXA

All alert types
0.95 USD -0.04 (-4.04%)

At closeNov 4, 2026, 4:00 PM EST

0.95 0.00 0.00%

After hours · Nov 4, 4:00 PM ET

0.95 Day range 1.02
0.95 52-week range 27.36
YTD
-91.10%
1 year
-90.97%

Revenue & Expenses

Income Tax Benefit → Expenses: $392.60KExpenses → Selling, General & Admin: $53.87MExpenses → Research & Development: $10.26MExpenses → Other Operating Expenses: $2.10MExpenses → Interest Expense: $3.55KExpenses → Other Expenses: $786.47KGross Profit → Expenses: $15.46KRevenue → Gross Profit: $15.46KRevenue → Cost of Revenue: $7.96KNet Loss → Expenses: $66.61MIncome Tax Benefit$392.60KGross Profit$15.46KNet Loss$66.61MCost of Revenue$7.96KExpenses$67.02MSelling, General & Admin$53.87MResearch & Development$10.26MOther Operating Expenses$2.10MInterest Expense$3.55KOther Expenses$786.47KRevenue$23.43K

Latest period ending Dec 31, 2025 · select a line to chart its full history

VRXA annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
23.43K0
15.46K0
-66.22M-28.92M
-66.61M-28.13M
-4.60-2.00
VRXA annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
1.61M5.36M
80.82M84.77M
96.59M53.71M
2.14M864.49K
-15.77M31.05M
VRXA annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
-9.90M-7.72M
-437.18K-120.88K
6.59M1.85M
-437.18K-120.88K
-3.75M-5.99M